- David Breen
AdventHealth is joining a collaboration with Quanterix Corporation and other leading health systems with the goal to improve and simplify Alzheimer’s disease diagnosis. These relationships further the company’s goal to build the global infrastructure necessary for Alzheimer’s testing by expanding clinical access to Quanterix’s leading blood biomarker tests.
In addition to AdventHealth, Mass General Brigham, the Mayo Clinic, the Medical University of South Carolina and UPMC will leverage Quanterix technology and tests to streamline care for Alzheimer’s patients. Quanterix is a Massachusetts-based company specializing in biomarker detection.
Blood-based biomarker testing offers Alzheimer’s patients a non-invasive method and greater access to testing overall. Traditionally, diagnosis has relied on a combination of symptom presentation, brain imaging, and the detection of biomarkers in the cerebrospinal fluid. This approach is not only burdensome and invasive for patients, but also costly, making them unsuitable for most primary and secondary care settings. This inaccessibility has left 50-70% of symptomatic Alzheimer’s patients without a correct and timely diagnosis.
“New resources available to aid in diagnosis and treatment of Alzheimer’s disease have contributed to a more optimistic environment for AD patient care,” said Kirk Erickson, PhD, director of translational neuroscience at the AdventHealth Neuroscience Institute. “With simplified, affordable, non-invasive testing methods, physicians can proactively evaluate and monitor patients with memory concerns. The availability of blood-based biomarker testing to the AdventHealth network has the potential to help a wide population concerned about mild cognitive impairment and aid physicians in their diagnosis.”
Read more here.
Recent News
On the newest Inspiring Wholeness podcast, Obie Diaz, local morning radio show host, shares how a routine physical eventually led to two open heart surgeries.
On the newest Inspiring Wholeness podcast, Obie Diaz, local morning radio show host, shares how a routine physical eventually led to two open heart surgeries.
Health care and government leaders celebrate the much-anticipated expansion of AdventHealth University.
Wangsness has more than 30 years of experience in health care.
‘Imagine Wholeness’ features the Grammy-winning group Take 6 and the AdventHealth Orchestra.
Bejarano will assume leadership on Dec. 15, 2024.
The 25th anniversary of ‘To Err is Human’ provides an opportunity to reflect on key learnings that have shaped the hospital system’s culture of safety.
AdventHealth has achieved the top spot on the Gartner Healthcare Supply Chain Top 25 for 2024.
Stories of support between AdventHealth patients and doctors showcase a healing circle of care.
Davis will provide executive oversight of AdventHealth’s newest division.
Johnson is a senior health care executive with nearly 20 years of leadership and operations experience.